{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T09:10:14Z","timestamp":1783933814549,"version":"3.55.0"},"reference-count":44,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U2CCA252971"],"award-info":[{"award-number":["U2CCA252971"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"City of Hope Cancer Control and Population Sciences Program","award":["P30CA033572"],"award-info":[{"award-number":["P30CA033572"]}]},{"name":"Drug Development and Capacity Building: UCR\/CoH-CCC Partnership","award":["U54CA285116"],"award-info":[{"award-number":["U54CA285116"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Early-onset colorectal cancer (EOCRC) is increasing disproportionately among Hispanic\/Latino (H\/L) populations and demonstrates substantial molecular and clinical heterogeneity. Although Wingless\/Integrated (WNT) pathway alterations are among the most common genomic events in colorectal cancer, their prognostic significance in the context of contemporary systemic therapies, including Bevacizumab, remains incompletely understood. We conducted an integrative clinical\u2013genomic analysis of colorectal cancer cohorts stratified by age at diagnosis, ancestry, and Bevacizumab exposure, interrogating somatic alterations across curated WNT signaling pathway genes. Conversational artificial intelligence agents (AI-HOPE and AI-HOPE-WNT) enabled dynamic cohort construction, treatment-specific subgroup analyses, and pathway-level interrogation through natural language-driven clinical\u2013genomic integration. WNT pathway alterations, predominantly involving APC, were highly prevalent across all cohorts; however, their distribution and clinical associations demonstrated strong treatment-, ancestry-, and age-dependent variability. Bevacizumab-treated tumors exhibited lower mutation frequencies in several WNT regulators, including RNF43, AXIN1\/2, TCF7L2, and AMER1, suggesting potential biologic interaction or treatment-related selective pressure. Importantly, WNT pathway alterations were associated with improved overall survival in H\/L EOCRC and Non-Hispanic White (NHW) late-onset colorectal cancer, but with worse survival in NHW EOCRC, highlighting distinct ancestry- and age-specific prognostic effects. These findings support the role of the WNT pathway dysregulation as a disparity-aware biomarker framework in colorectal cancer and demonstrate the utility of conversational AI systems for scalable multidimensional clinical\u2013genomic integration in precision oncology.<\/jats:p>","DOI":"10.3390\/ijms27146195","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:53:58Z","timestamp":1783932838000},"page":"6195","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Artificial Intelligence-Enabled Analysis of WNT Pathway Dysregulation in Bevacizumab-Treated Early-Onset Colorectal Cancer"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0446-123X","authenticated-orcid":false,"given":"Erika","family":"Ruiz-Garcia","sequence":"first","affiliation":[{"name":"Translational Medicine Laboratory, GI Oncology Department, INCAN\u2014Instituto Nacional de Cancerolog\u00eda, Ciudad de M\u00e9xico 14080, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5991-9779","authenticated-orcid":false,"given":"Brigette","family":"Waldrup","sequence":"additional","affiliation":[{"name":"Department of Integrative Translational Sciences, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1789-4197","authenticated-orcid":false,"given":"Francisco G.","family":"Carranza","sequence":"additional","affiliation":[{"name":"Department of Integrative Translational Sciences, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Manjarrez","sequence":"additional","affiliation":[{"name":"Department of Integrative Translational Sciences, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5159-8300","authenticated-orcid":false,"given":"Edith A.","family":"Fernandez-Figueroa","sequence":"additional","affiliation":[{"name":"N\u00facleo B de Innovaci\u00f3n en Medicina de Precisi\u00f3n, Instituto Nacional de Medicina Gen\u00f3mica, Ciudad de M\u00e9xico 14610, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3603-6414","authenticated-orcid":false,"given":"Enrique","family":"Velazquez-Villarreal","sequence":"additional","affiliation":[{"name":"Department of Integrative Translational Sciences, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA"},{"name":"Comprehensive Cancer Center, City of Hope, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S2468-1253(21)00426-X","article-title":"The rising tide of early-onset colorectal cancer: A comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection","volume":"7","author":"Patel","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_2","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1470-2045(24)00600-4","article-title":"Colorectal cancer incidence trends in younger versus older adults: An analysis of population-based cancer registry data","volume":"26","author":"Sung","year":"2025","journal-title":"Lancet Oncol."},{"key":"ref_4","first-page":"1039","article-title":"Colorectal cancer incidence among Hispanics and non-Hispanic Whites in the United States","volume":"29","author":"Garcia","year":"2018","journal-title":"Cancer Causes Control."},{"key":"ref_5","first-page":"466","article-title":"Cancer statistics for the US Hispanic\/Latino population, 2021","volume":"71","author":"Miller","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Muller, C., Ihionkhan, E., Stoffel, E.M., and Kupfer, S.S. (2021). Disparities in Early-Onset Colorectal Cancer. Cells, 10.","DOI":"10.3390\/cells10051018"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1158\/1055-9965.EPI-16-0684","article-title":"Cancer Mortality in Hispanic Ethnic Groups","volume":"26","author":"Pinheiro","year":"2017","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_8","first-page":"286","article-title":"Comparative Effectiveness Research: The Impact of Biologic Agents in Ethnic Minorities with Metastatic Colorectal Cancer","volume":"16","author":"Goel","year":"2017","journal-title":"Clin. Color. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12094-025-04006-9","article-title":"Incidence trends of colorectal cancer in young adults in Spain","volume":"28","author":"Galceran","year":"2025","journal-title":"Clin. Transl. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.1158\/1078-0432.CCR-19-0899","article-title":"Comprehensive Genomic Landscapes in Early and Later Onset Colorectal Cancer","volume":"25","author":"Lieu","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Storandt, M.H., Shi, Q., Eng, C., Lieu, C., George, T., Stoppler, M.C., Mauer, E., Yilma, B., Fragkogianni, S., and Teslow, E.A. (2025). Genomic Landscapes of Early-Onset Versus Average-Onset Colorectal Cancer Populations. Cancers, 17.","DOI":"10.3390\/cancers17050836"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"152805","DOI":"10.1016\/j.imbio.2024.152805","article-title":"The heterogeneity of tumour-associated macrophages contributes to the clinical outcomes and indications for immune checkpoint blockade in colorectal cancer patients","volume":"229","author":"Tang","year":"2024","journal-title":"Immunobiology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/1354750X.2024.2447089","article-title":"Mutational and co-mutational landscape of early onset colorectal cancer","volume":"30","author":"Alshenaifi","year":"2025","journal-title":"Biomarkers"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Antelo, M., Balaguer, F., Shia, J., Shen, Y., Hur, K., Moreira, L., Cuatrecasas, M., Bujanda, L., Giraldez, M.D., and Takahashi, M. (2012). A high degree of LINE-1 hypomethylation is a unique feature of early-onset colorectal cancer. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0045357"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Diaz, F.C., Waldrup, B., Carranza, F.G., Manjarrez, S., and Velazquez-Villarreal, E. (2025). Precision Oncology Insights into WNT Pathway Alterations in FOLFOX-Treated Early-Onset Colorectal Cancer in High-Risk Populations. Cancers, 17.","DOI":"10.1101\/2025.08.02.25332877"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Diaz, F.C., Waldrup, B., Carranza, F.G., Manjarrez, S., and Velazquez-Villarreal, E. (2025). Artificial Intelligence-Enhanced Precision Medicine Reveals Prognostic Impact of TGF-Beta Pathway Alterations in FOLFOX-Treated Early-Onset Colorectal Cancer Among Disproportionately Affected Populations. Int. J. Mol. Sci., 26.","DOI":"10.1101\/2025.08.11.25333363"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Monge, C., Waldrup, B., Carranza, F.G., and Velazquez-Villarreal, E. (2024). WNT and TGF-Beta Pathway Alterations in Early-Onset Colorectal Cancer Among Hispanic\/Latino Populations. Cancers, 16.","DOI":"10.1101\/2024.10.17.24315250"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Monge, C., Waldrup, B., Carranza, F.G., and Velazquez-Villarreal, E. (2025). Ethnicity-Specific Molecular Alterations in MAPK and JAK\/STAT Pathways in Early-Onset Colorectal Cancer. Cancers, 17.","DOI":"10.1101\/2025.02.17.25322443"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e70791","DOI":"10.1002\/cam4.70791","article-title":"Detecting PI3K and TP53 Pathway Disruptions in Early-Onset Colorectal Cancer Among Hispanic\/Latino Patients","volume":"14","author":"Monge","year":"2025","journal-title":"Cancer Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13578-019-0361-4","article-title":"Signaling pathways involved in colorectal cancer progression","volume":"9","author":"Koveitypour","year":"2019","journal-title":"Cell Biosci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"9390878","DOI":"10.1155\/2020\/9390878","article-title":"Role of Wnt\/\u03b2-Catenin Signaling in the Chemoresistance Modulation of Colorectal Cancer","volume":"2020","author":"Yuan","year":"2020","journal-title":"BioMed Res. Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12943-022-01616-7","article-title":"Wnt signaling in colorectal cancer: Pathogenic role and therapeutic target","volume":"21","author":"Zhao","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.semcancer.2019.01.001","article-title":"Overview of the oncogenic signaling pathways in colorectal cancer: Mechanistic insights","volume":"58","author":"Farooqi","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"115172","DOI":"10.1016\/j.ejca.2024.115172","article-title":"Prognosis of early-onset versus late-onset sporadic colorectal cancer: Systematic review and meta-analysis","volume":"215","author":"Carbone","year":"2025","journal-title":"Eur. J. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41416-024-02902-5","article-title":"Early onset metastatic colorectal cancer patients as a distinctive clinical and molecular phenomenon","volume":"132","author":"Pretta","year":"2025","journal-title":"Br. J. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejca.2018.10.009","article-title":"Efficacy of bevacizumab in first-line treatment of metastatic colorectal cancer: A systematic review and meta-analysis","volume":"106","author":"Baraniskin","year":"2019","journal-title":"Eur. J. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"102017","DOI":"10.1016\/j.ctrv.2020.102017","article-title":"Bevacizumab (Avastin\u00ae) in cancer treatment: A review of 15 years of clinical experience and future outlook","volume":"86","author":"Garcia","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.3748\/wjg.v21.i16.5072","article-title":"Value of bevacizumab in treatment of colorectal cancer: A meta-analysis","volume":"21","author":"Qu","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Zhu, Y., and Li, X. (2023). Advances of Wnt Signalling Pathway in Colorectal Cancer. Cells, 12.","DOI":"10.3390\/cells12030447"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000163850","article-title":"Bevacizumab improves the overall and progression-free survival of patients with metastatic colorectal cancer treated with 5-fluorouracil-based regimens irrespective of baseline risk","volume":"75","author":"Kabbinavar","year":"2008","journal-title":"Oncology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/nrc909","article-title":"VEGF and the quest for tumour angiogenesis factors","volume":"2","author":"Ferrara","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1200\/JCO.2007.14.9930","article-title":"Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: A randomized phase III study","volume":"26","author":"Saltz","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1477-7819-8-82","article-title":"Young patients with colorectal cancer have poor survival in the first twenty months after operation and predictable survival in the medium and long-term: Analysis of survival and prognostic markers","volume":"8","author":"Chan","year":"2010","journal-title":"World J. Surg. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1200\/JCO.2015.65.0994","article-title":"Racial\/Ethnic Disparities in Survival Among Patients with Young-Onset Colorectal Cancer","volume":"34","author":"Holowatyj","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.cmet.2013.08.001","article-title":"Role of endothelial cell metabolism in vessel sprouting","volume":"18","author":"Georgiadou","year":"2013","journal-title":"Cell Metab."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1091\/mbc.e06-04-0320","article-title":"Wnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2","volume":"17","author":"Agalliu","year":"2006","journal-title":"Mol. Biol. Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1200\/JCO.2026.44.2_suppl.235","article-title":"WNT pathway alterations in bevacizumab-treated early-onset colorectal cancer: An artificial intelligence\u2013driven and disparity-aware precision oncology analysis","volume":"44","author":"Waldrup","year":"2026","journal-title":"J. Clin. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"btaf359","DOI":"10.1093\/bioinformatics\/btaf359","article-title":"AI-HOPE: An AI-driven conversational agent for enhanced clinical and genomic data integration in precision medicine research","volume":"41","author":"Yang","year":"2025","journal-title":"Bioinformatics"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Yang, E.W., Waldrup, B., and Velazquez-Villarreal, E. (2025). Conversational AI agent for precision oncology: AI-HOPE-WNT integrates clinical and genomic data to investigate WNT pathway dysregulation in colorectal cancer. Front. Artif. Intell., 8.","DOI":"10.3389\/frai.2025.1624797"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1200\/JCO.2025.43.16_suppl.3603","article-title":"Enhancing colorectal cancer precision medicine through multi-omics and clinical data integration with artificial intelligence","volume":"43","author":"Yang","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s12687-023-00686-4","article-title":"Genetic risk prediction in Hispanics\/Latinos: Milestones, challenges, and social-ethical considerations","volume":"14","author":"Maldonado","year":"2023","journal-title":"J. Community Genet."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Waldrup, B., Carranza, F., Jin, Y., Amzaleg, Y., Postel, M., Craig, D.W., Carpten, J.D., Salhia, B., Ricker, C.N., and Culver, J.O. (2024). Integrative multi-omics profiling of colorectal cancer from a Hispanic\/Latino cohort of patients medRxiv: 2024.11.03.24316599. medRxiv.","DOI":"10.1101\/2024.11.03.24316599"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Carranza, F.G., Waldrup, B., Jin, Y., Amzaleg, Y., Postel, M., Craig, D.W., Carpten, J.D., Salhia, B., Hernandez, D., and Gutierrez, N. (2025). Assessment of MYC Gene and WNT Pathway Alterations in Early-Onset Colorectal Cancer Among Hispanic\/Latino Patients Using Integrated Multi-Omics Approaches. medRxiv, medRxiv:2024.12.05.24318588.","DOI":"10.1101\/2024.12.05.24318588"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2147\/JHC.S412446","article-title":"Hispanic Individuals are Underrepresented in Phase III Clinical Trials for Advanced Liver Cancer in the United States","volume":"10","author":"Monge","year":"2023","journal-title":"J. Hepatocell. Carcinoma"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/14\/6195\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:55:18Z","timestamp":1783932918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/14\/6195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":44,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["ijms27146195"],"URL":"https:\/\/doi.org\/10.3390\/ijms27146195","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]}}}